09 January 2024
Despite the ongoing global discourse on the ethical implications of artificial intelligence, a groundbreaking initiative, TOLIFE, is taking advantage of this cutting-edge technology to revolutionize healthcare.
In a recent feature in Exl, a magazine dedicated to showcasing excellence in technology, innovation, research, and enterprise, CNR engineer Marco Laurino provides deeper insights into the TOLIFE project.
Funded by the Horizon Europe framework of the European Union, TOLIFE aims to forge a platform that seamlessly integrates non-invasive artificial intelligence and sensor technology. The focus is on advancing the management and personalization of treatments for chronic obstructive pulmonary disease (COPD). Leveraging data from wearable sensors embedded in smartphones, smartwatches, and smart shoes, as well as strategically placed home devices, the project seeks to amass comprehensive Big Data reflecting patients’ daily activities.
This rich dataset, harmonized through a cloud-based platform, undergoes meticulous analysis by sophisticated algorithms. The objective is twofold:
- to predict early onsets of disease exacerbations;
- to provide continuous health monitoring for patients.
TOLIFE aspires to implement swift, tailored treatments that not only enhance the quality of life for patients but also contribute to significant reductions in healthcare costs. Spearheaded by the University of Pisa, the project brings together a dynamic, international consortium across multiple disciplines.
